SCILLS - The Scottish Institute for Cell Signalling

SCILLS is dedicated to the study of how biological processes are controlled and how they become deregulated in disease. The Protein Ubiquitination Unit is the Institute's first research Division. Its major aims are to advance understanding of the role of protein ubiquitination and related modifications in cell regulation and human disease, to facilitate the development of drugs to treat diseases caused by abnormalities in this process, to generate reagents and improve technologies on which more rapid progress in this area depends, and to train the next generation of scientists who will advance the subject.

News

Member of the SCILLS Scientific Advisory Group Honoured. December 31st 2009

SCILLS sends its heartiest congratulations to Professor Karen Vousden, the Director of the Beatson Institute for Cancer Research, Glasgow, and a member of the Scientific Advisory Group of SCILLS, who was today made a CBE (Commander of the British Empire) in the Queen's New Year's Honours. Karen, who is most famous for her discovery of MDM2, the E3 ubiquitin ligase that destroys the tumour suppressor p53, became Director of the Beatson Cancer Institute in 2002. Prior to that Karen was the Head of Molecular Carcinogenesis and Chief of the Regulation of Cell Growth Laboratory at the National Cancer Institute, Frederick, USA from 1995-2002.

Return to News Archive